BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32751918)

  • 21. Analysis of CTCL cell lines reveals important differences between mycosis fungoides/Sézary syndrome
    Netchiporouk E; Gantchev J; Tsang M; Thibault P; Watters AK; Hughes JM; Ghazawi FM; Woetmann A; Ødum N; Sasseville D; Litvinov IV
    Oncotarget; 2017 Nov; 8(56):95981-95998. PubMed ID: 29221181
    [No Abstract]   [Full Text] [Related]  

  • 22. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma.
    Beljaards RC; Meijer CJ; Van der Putte SC; Hollema H; Geerts ML; Bezemer PD; Willemze R
    J Pathol; 1994 Jan; 172(1):53-60. PubMed ID: 7931828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Ectopic Expression of Meiosis Regulatory Genes in Cutaneous T-Cell Lymphomas (CTCL).
    Gantchev J; Martínez Villarreal A; Xie P; Lefrançois P; Gunn S; Netchiporouk E; Sasseville D; Litvinov IV
    Front Oncol; 2019; 9():429. PubMed ID: 31214493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocosis fungoides--an update on a non-mycotic disease.
    Makdisi J; Friedman A
    J Drugs Dermatol; 2013 Jul; 12(7):825-31. PubMed ID: 23884501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New perspectives in experimental and clinical research for cutaneous T cell lymphomas.
    Burg G; Häffner A; Böni R; Dommann S; Dummer R
    Recent Results Cancer Res; 1995; 139():225-37. PubMed ID: 7597294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective Analysis of 118 Patients With Cutaneous T-Cell Lymphomas: A Single-Center Experience.
    Polgárová K; Polívka J; Kodet O; Klener P; Trněný M
    Front Oncol; 2022; 12():884091. PubMed ID: 35747818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-cell receptor beta variable region (V beta) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skin.
    Potoczna N; Boehncke WH; Nestle FO; Küenzlen C; Sterry W; Burg G; Dummer R
    J Cutan Pathol; 1996 Aug; 23(4):298-305. PubMed ID: 8864915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in understanding and managing cutaneous T-cell lymphomas.
    Brunner PM; Jonak C; Knobler R
    F1000Res; 2020; 9():. PubMed ID: 32419924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous T cell lymphoma-mycosis fungoides and Sezary syndrome: an update.
    Parker SR; Bethaney JV
    G Ital Dermatol Venereol; 2009 Aug; 144(4):467-85. PubMed ID: 19755952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on Biology of Cutaneous T-Cell Lymphoma.
    Phyo ZH; Shanbhag S; Rozati S
    Front Oncol; 2020; 10():765. PubMed ID: 32477957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous T cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases.
    Fouchard N; Mahe A; Huerre M; Fraitag S; Valensi F; Macintyre E; Sanou F; de The G; Gessain A
    Leukemia; 1998 Apr; 12(4):578-85. PubMed ID: 9557617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous lymphoma: Kids are not just little people.
    Ferenczi K; Makkar HS
    Clin Dermatol; 2016; 34(6):749-759. PubMed ID: 27968935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spatially Guided and Single Cell Tools to Map the Microenvironment in Cutaneous T-Cell Lymphoma.
    Kalliara E; Belfrage E; Gullberg U; Drott K; Ek S
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonal disease in extracutaneous compartments in cutaneous T-cell lymphomas. A comparative study between cutaneous T-cell lymphomas and pseudo lymphomas.
    Dommann SN; Dommann-Scherrer CC; Dours-Zimmermann MT; Zimmermann DR; Kural-Serbes B; Burg G
    Arch Dermatol Res; 1996 Apr; 288(4):163-7. PubMed ID: 8967786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Update on Molecular Biology of Cutaneous T Cell Lymphoma.
    Walia R; Yeung CCS
    Front Oncol; 2019; 9():1558. PubMed ID: 32039026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
    Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
    Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes.
    Laharanne E; Oumouhou N; Bonnet F; Carlotti M; Gentil C; Chevret E; Jouary T; Longy M; Vergier B; Beylot-Barry M; Merlio JP
    J Invest Dermatol; 2010 Jun; 130(6):1707-18. PubMed ID: 20130593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunobiology and treatment of cutaneous T-cell lymphoma.
    Goel RR; Rook AH
    Expert Rev Clin Immunol; 2024 Mar; ():1-12. PubMed ID: 38450476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.